Certified by Founder Lodge 
                                        
                                        Brenus Pharma
 France  -  Lyon
 
                                                 France  -  Lyon 
                                             START UP 
                                                                                    1 Disclosed Funding Rounds $25,000,000
                                            0 Participating Investments
- 
                                                Founded date 
                                                2019 
- 
                                                Operating Status 
                                                Active 
- 
                                                Last Funding Type 
                                                Seed 
- 
                                                Company Type 
                                                For Profit 
- Website
- Contact
- Social Links
                                            Brenus Pharma is a French clinical-stage biotech developing a pioneering technology platform, Stimulated-Tumor-Cell (STC) designed to generate 'first-in-class', 'off-the-shelf' therapeutic ca
                                        
                                        
                                        
                                                                                
                                        
                                                                                | Date | Round | Raised | Participating Investors | 
|---|---|---|---|
| September, 19 ,2024 | Series A | $25,000,000 | 
 
                                                 UI Investissement
 UI Investissement
                                                                                 IDRx
IDRx 
 
                                             CAMP4 Therapeutics
CAMP4 Therapeutics Delfi Diagnostics
Delfi Diagnostics xilis
xilis Manifold Bio
Manifold Bio IORGANBIO |  $2,000,000  | (Oct 30, 2025)
                                                                        
                                IORGANBIO |  $2,000,000  | (Oct 30, 2025) Sparrow BioAcoustics |  $10,000,000  | (Oct 30, 2025)
                                                                        
                                Sparrow BioAcoustics |  $10,000,000  | (Oct 30, 2025) 
                             Vesence |  $9,000,000  | (Oct 30, 2025)
                                                                        
                                Vesence |  $9,000,000  | (Oct 30, 2025) Homecourt |  $8,000,000  | (Oct 30, 2025)
                                                                        
                                Homecourt |  $8,000,000  | (Oct 30, 2025) Reflectiz |  $22,000,000  | (Oct 30, 2025)
                                                                        
                                Reflectiz |  $22,000,000  | (Oct 30, 2025) 
                             
                                                 
                                                     
                                                 
                                                 
                                                 
                                                 
                                                     
                                                 
                                                 
                                                 
                                                